IKM — 1nkemia IUCT SA Income Statement
0.000.00%
HealthcareHighly SpeculativeMicro Cap
Annual income statement for 1nkemia IUCT SA, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2018 December 31st | R2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | — | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 5.46 | 1.74 | 0.146 | 0.148 | 0.043 |
Cost of Revenue | |||||
Gross Profit | 4.99 | 2.93 | 0.076 | 0.136 | 0.097 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 20.2 | -2.16 | 2.53 | -0.572 | 0.123 |
Operating Profit | -14.8 | 3.89 | -2.39 | 0.72 | -0.08 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | -15.6 | 3.59 | -2.65 | -0.119 | -0.505 |
Provision for Income Taxes | |||||
Net Income After Taxes | -24.4 | 3.54 | -2.65 | -0.119 | -0.505 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | -24.3 | 3.7 | -2.65 | -0.113 | -0.506 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -24.3 | 3.7 | -2.65 | -0.113 | -0.506 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.482 | 0.012 | -0.022 | -0.038 | -0.019 |
Dividends per Share |